Short Interest in Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Declines By 66.9%

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL - Get Free Report) was the target of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 4,900 shares, a drop of 66.9% from the February 28th total of 14,800 shares. Currently, 0.1% of the company's stock are short sold. Based on an average daily trading volume, of 15,100 shares, the days-to-cover ratio is presently 0.3 days.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of CCEL. Northern Trust Corp lifted its position in shares of Cryo-Cell International by 78.2% in the fourth quarter. Northern Trust Corp now owns 38,902 shares of the company's stock valued at $288,000 after buying an additional 17,066 shares during the last quarter. Topline Capital Management LLC bought a new stake in Cryo-Cell International in the 4th quarter valued at $354,000. CreativeOne Wealth LLC acquired a new stake in Cryo-Cell International during the 4th quarter valued at $113,000. Heron Bay Capital Management bought a new position in Cryo-Cell International during the fourth quarter worth $235,000. Finally, Rowlandmiller & PARTNERS.ADV acquired a new position in shares of Cryo-Cell International in the fourth quarter valued at $107,000. Institutional investors own 10.44% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Maxim Group decreased their price objective on Cryo-Cell International from $9.00 to $8.50 and set a "buy" rating for the company in a report on Tuesday, March 4th.

Remove Ads

Cryo-Cell International Stock Up 2.0 %

Shares of Cryo-Cell International stock traded up $0.13 on Monday, reaching $6.43. 1,340 shares of the company were exchanged, compared to its average volume of 12,422. The stock has a market cap of $51.79 million, a P/E ratio of -6.06 and a beta of 0.53. Cryo-Cell International has a one year low of $5.75 and a one year high of $9.50.

Cryo-Cell International Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 15.56%. The ex-dividend date was Friday, February 14th. Cryo-Cell International's dividend payout ratio is currently -94.34%.

Cryo-Cell International Company Profile

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.